Randomized Control Study of Concerta and Strattera on the Improvement of Executive Function in Attention Deficit Hyperactivity Disorder Children

NCT01065259 Phase 4 COMPLETED

The objective of this study is to compare the effect of Concerta (Osmotic Release Oral System Extended Release Methylphenidate HCL, OROS MPH) and Strattera (Atomoxetine) on the laboratory and ecological executive function in children with attention deficit hyperactivity disorder.

Details

Lead sponsor	Peking University
Phase	Phase 4
Status	COMPLETED
Enrolment	262
Start date	2008-04
Completion	2010-12

Conditions

• Attention Deficit Hyperactivity Disorder

Interventions

• OROS MPH
• Atomoxetine

Primary outcomes

• Executive function test — seven to ten weeks

Countries

China